Penumbra (NYSE:PEN) has received FDA clearance and launched its Ruby XL system for embolization procedures. The Alameda, California-based device maker launched the platform as a new option for physicians treating high-flow or large-vessel cases. The Ruby XL system includes three new coils that are compatible with 0.035-inch diagnostic catheters and offer coils up to 40 mm […]
Penumbra
Penumbra has positive data for computer-assisted vacuum thrombectomy system
Penumbra (NYSE:PEN) today announced new data demonstrating improved outcomes with its computer-assisted vacuum thrombectomy (CAVT) technology. Data evaluated the use of the CAVT technology in people with intermediate-risk pulmonary embolism (PE). Results showed that those treated with CAVT had shorter hospital stay lengths, shorter post-procedure stay length and fewer complications when compared to other treatment […]
Penumbra wins CE mark for computer-assisted thrombectomy tech
Penumbra (NYSE:PEN) announced today that it received CE mark approval for its computer-assisted vacuum thrombectomy (CAVT) technologies. The Lightning Flash 2.0 and Lightning Bolt 7 offerings from the Alameda, California-based company both picked up European approval. Penumbra said approval makes its Lightning products the only CAVT systems available in Europe. The company’s latest offerings set […]
Penumbra announces $200M share repurchase program
Penumbra (NYSE:PEN) announced today that its board of directors approved a share repurchase authorization of up to $200 million. Alameda, California-based Penumbra said in a news release that its board approved the repurchase on Aug. 5. It allows the company to repurchase its common stock from time to time at such prices as it deems […]
Penumbra launches duo of stroke catheters in Europe
Penumbra (NYSE:PEN) announced today that, with CE mark approval, it launched its new BMX81 and BMX96 neuro access devices in Europe. The company designed the devices for the neurovascular management of ischemic and hemorrhagic stroke. Penumbra said they represent its “most advanced neuro access offerings,” according to a news release. The launch further expands the […]
FDA clears computer-assisted thrombectomy system from Penumbra
Penumbra (NYSE:PEN) announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system. Lightning Flash 2.0 represents the next generation of the company’s computer-assisted vacuum thrombectomy (CAVT) technology. It removes the venous thrombus to treat pulmonary emboli (PE). The system features Lightning Flash algorithms designed for increased […]
First patient enrolled in Penumbra study of computer-assisted vacuum thrombectomy
Penumbra (NYSE:PEN) today announced the first patient enrolled in STORM-PE, a trial of its Lightning Flash thrombectomy system. Lightning Flash, a mechanical thrombectomy system, received FDA clearance in January. The system features Penumbra’s novel Lightning intelligent aspiration technology with dual-clot detection algorithms. Combining it with innovative catheter engineering, Penumbra designed Lightning Flash to quickly remove […]
Penumbra, Veterans Health Administration expand access to rehab with VR
Penumbra (NYSE:PEN) today announced a collaboration with the Veterans Health Administration (VHA) Office of Healthcare Innovation and Learning (OHIL). The collaboration covers testing, co-developing and implementing rehabilitative healthcare solutions through virtual reality (VR). Building on Penumbra’s REAL y-Series technology, the collaboration focuses on developing targeted therapy tools. These tools address the most critical rehabilitation needs […]
Penumbra grows sales 8% in Q4
Penumbra (NYSE:PEN) this week posted fourth-quarter results that beat the overall consensus on Wall Street. The Alameda, California-based company — maker of interventional devices for vascular and neuro therapies — reported profits of $3.9 million, or 10¢ per share, on sales of $221.2 million, for the three months ended Dec. 31, 2022. Sales were up 8.43% […]
FDA clears Lightning Flash thrombectomy system from Penumbra
Penumbra (NYSE:PEN) announced today that it received FDA clearance for the Lightning Flash mechanical thrombectomy system. Alameda, California-based Penumbra also initiated the launch for the system. The company called Lightning Flash “the most advanced and powerful mechanical thrombectomy system on the market.” Lightning Flash features the company’s novel Lightning intelligent aspiration technology with dual-clot detection […]
Penumbra launches VR-based rehab platform
Penumbra (NYSE:PEN) announced today that it launched a full-body, non-tethered immersive healthcare offering for rehabilitation. Alameda, California–based Penumbra designed its REAL y-Series product with lower and upper body sensors. They allow clinicians to track full-body movement and progress in real-time. By expanding its virtual reality-based immersive healthcare platform, Penumbra plans to support a broad range […]
